Donate
Thank You, I really need your help.
Categories
Archives
Friends of Fibro
May 2013 M T W T F S S « Apr 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31
Category Archives: Medication News
FDA Approves First Opioid for Diabetic Peripheral Neuropathy
The U.S. Food and Drug Administration has approved the use of the first opioid painkiller for the treatment of neuropathic pain caused by diabetic peripheral neuropathy. Nucynta, which is made by Janssen Pharmaceuticals, is already approved for management of moderate to severe chronic pain in adults.
Continue reading
Gabapentin for chronic neuropathic pain and fibromyalgia in adults
Antiepileptic drugs like gabapentin are commonly used for treating neuropathic pain, usually defined as pain due to damage to nerves. This would include postherpetic neuralgia (persistent pain experienced in an area previously affected by shingles), painful complications of diabetes, nerve injury pain, phantom limb pain, fibromyalgia and trigeminal neuralgia. This type of pain can be severe and long‐lasting, is associated with lack of sleep, fatigue, and depression, and a reduced quality of life. Continue reading
7 myths about the risks and dangers of opioid analgesics
Celebrity magazines all too often feature stories about overdose deaths and rehab admissions, and the Office of National Drug Control Policy is running an advertising campaign about the dangers of prescription drug abuse.
Continue reading
Mortality in fibromyalgia: An 8,186 Patient Study Over 35 Years
We studied 8,186 fibromyalgia patients seen between 1974 and 2009 in 3 settings: all fibromyalgia patients in a clinical practice, patients participating in the US National Data Bank for Rheumatic Diseases (NDB), and patients invited to participate in the NBD who refused participation. Internal controls included 12, 329 patients with osteoarthritis. Deaths were determined by multiple source communication, and all patients were also screened in the US National Death Index (NDI). Continue reading
Posted in Fibromyalgia, Medication News
Tagged chronic fatigue and fibromyalgia, fibomyalgia, Fibro, fight fibromyalgia
Leave a comment
FDA slaps Eli Lilly for ‘false or misleading claims’ in ads for Cymbalta
INDIANAPOLIS, Indiana — The U.S. Food and Drug Administration has slapped drugmaker Eli Lilly & Co. on the wrist for making “false or misleading claims” in advertisements for Cymbalta, a drug for pain and anxiety relief. Continue reading
Posted in General Health News, Medication News
Tagged chronic fatigue syndrome, cymbalta, lilly, misleading
Leave a comment
What are the disadvantages and side effects of cortisone injections?
Disadvantages of cortisone injections are the necessity of piercing the skin with a needle as well as potential short- and long-term side effects. It should be emphasized that though each of these side effects is possible, they usually do not occur. Continue reading
Posted in Chronic Pain Syndrone, Medication News
Tagged Fibro, joint pain, pain, rheumatoid arthritis
Leave a comment
Simple and inexpensive ways to Limit swine flu
Here’s some good information – I never thought about the nose/throat thing. Sounds simple enough and would be worth it – not just for H1N1, but for any virus. Thought you might want to know this helpful information. This man spoke at WRMC ( Weatherford Regional Medical Center ) last week. Good advice to share with your family and friends. Continue reading
The Dr. Oz Bait for Vaccines: Why Did He Do It?
Dr. Mehmet Oz, talk show host and Vice-Chair and Professor of Surgery at Columbia University is perhaps the most well-known doctors in the U.S. During a recent episode on his talk show, a Walgreens pharmacist gave Dr. Oz a flu … Continue reading
A Negative Verdict for Glucosamine and Chondroitin Supplements
The most recent study on glucosamine and chondroitin supplements seriously challenges their effectiveness at providing relief from osteoarthritis pain. Continue reading
Posted in Medication News
Tagged Arthritis, arthritis treatment, chondroitin, glu, glucosamine
Leave a comment
Nutra Pharma Announces Launch of Cobroxin, an Over-the-Counter (OTC) Treatment for Stage 2 (Moderate to Severe) Chronic Pain
Cobroxin is the first OTC pain reliever clinically proven to treat Stage 2 (moderate to severe) chronic pain. The drug, which was developed by Nutra Pharma’s wholly-owned drug discovery subsidiary, ReceptoPharm, will be available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating repetitive stress, arthritis, and joint pain Continue reading
Secured by